Literature DB >> 8103567

Molecular characterization of the ldmdr1 multidrug resistance gene from Leishmania donovani.

N Hendrickson1, C D Sifri, D M Henderson, T Allen, D F Wirth, B Ullman.   

Abstract

The ldmdr1 gene that confers resistance to multiple structurally dissimilar hydrophobic drugs in Leishmania donovani has been isolated within a 5.4-kb XmaI fragment from a genomic library of L. donovani DNA and its protein coding region sequenced. The longest open reading frame within ldmdr1 encodes a 146.5-kDa protein of 1341 amino acids, designated LDMDR1. The primary structure and predicted membrane topology of LDMDR1 indicates that it is a member of the P-glycoprotein superfamily with the greatest homology to the mammalian multidrug resistance P-glycoproteins. A 2.3-kb SalI fragment derived from a second ldmdr1 allele was also cloned from the L. donovani library. Nucleotide sequence analysis of a portion of the SalI insert revealed 5 single base differences from its counterpart within the 5.4-kb XmaI fragment, one of which created a PvuI restriction site polymorphism. Southern blots of PvuI-digested DNA divulged that the amplified ldmdr1 gene copies in a multidrug-resistant L. donovani strain were all derived from the single ldmdr1 allele whose protein coding segment was sequenced in its entirety.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103567     DOI: 10.1016/0166-6851(93)90028-v

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

Review 1.  Multidrug resistance--a fascinating, clinically relevant problem in bioenergetics.

Authors:  P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

Review 2.  The biology of the P-glycoproteins.

Authors:  C R Leveille-Webster; I M Arias
Journal:  J Membr Biol       Date:  1995-01       Impact factor: 1.843

3.  In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.

Authors:  F Faraut-Gambarelli; R Piarroux; M Deniau; B Giusiano; P Marty; G Michel; B Faugère; H Dumon
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

4.  Geographical Distribution of MDR1 Expression in Leishmania Isolates, from Greece and Cyprus, Measured by the Rhodamine-123 Efflux Potential of the Isolates, Using Flow Cytometry.

Authors:  Nikolaos Tsirigotakis; Vasiliki Christodoulou; Pantelis Ntais; Apostolos Mazeris; Eleni Koutala; Ippokratis Messaritakis; Maria Antoniou
Journal:  Am J Trop Med Hyg       Date:  2016-03-21       Impact factor: 2.345

5.  Detection of drug resistance gene in cutaneous leishmaniasis by PCR in some endemic areas of iran.

Authors:  R Alizadeh; H Hooshyar; M Bandehpor; M Arbabi; F Kazemi; A Talari; B Kazemi
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

6.  Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression.

Authors:  Ippokratis Messaritakis; Vasiliki Christodoulou; Apostolos Mazeris; Eleni Koutala; Antonia Vlahou; Sevasti Papadogiorgaki; Maria Antoniou
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

7.  A P-glycoprotein protects Caenorhabditis elegans against natural toxins.

Authors:  A Broeks; H W Janssen; J Calafat; R H Plasterk
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

8.  Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy.

Authors:  Alicia Ponte-Sucre
Journal:  Kinetoplastid Biol Dis       Date:  2003-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.